William Blair & Company’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-89,400
| Closed | -$952K | – | 1810 |
|
|
2022
Q4 | $952K | Sell |
89,400
-14,566
| -14% | -$155K | ﹤0.01% | 834 |
|
|
2022
Q3 | $767K | Buy |
103,966
+6,000
| +6% | +$44.3K | ﹤0.01% | 904 |
|
|
2022
Q2 | $471K | Sell |
97,966
-2,600
| -3% | -$12.5K | ﹤0.01% | 1086 |
|
|
2022
Q1 | $514K | Buy |
100,566
+13,700
| +16% | +$70K | ﹤0.01% | 1151 |
|
|
2021
Q4 | $522K | Buy |
86,866
+4,500
| +5% | +$27K | ﹤0.01% | 1198 |
|
|
2021
Q3 | $730K | Buy |
82,366
+30,900
| +60% | +$274K | ﹤0.01% | 1035 |
|
|
2021
Q2 | $407K | Buy |
51,466
+16,700
| +48% | +$132K | ﹤0.01% | 1226 |
|
|
2021
Q1 | $265K | Buy |
+34,766
| New | +$265K | ﹤0.01% | 1378 |
|
|
2019
Q2 | – | Sell |
-567
| Closed | -$8K | – | 1729 |
|
|
2019
Q1 | $8K | Buy |
+567
| New | +$8K | ﹤0.01% | 1633 |
|